ESRX Insider Trading Activity and SEC Form 4 Filings
ESRX insider trading summary
No open-market insider purchases or sales of Express Scripts Holding Co. (ESRX) have been reported on SEC Form 4 in the past 12 months.
Latest ESRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 7, 2018 | Mahon Thomas P Mac | Director | Sell | $521K (5,234 @ $99.50) |
| Aug 10, 2018 | Christine Houston | Executive Vice President | Sell | $1.1M (12,898 @ $85.00) |
| Jun 13, 2018 | Christine Houston | Executive Vice President | Sell | $823K (10,000 @ $82.28) |
| Mar 15, 2018 | Christine Houston | Executive Vice President | Sell | $1.5M (19,889 @ $76.69) |
| Mar 1, 2018 | Everett Neville | Exe VP, Strat, Sup Chn & Spclt | Sell | $368K (4,895 @ $75.26) |
| Jan 11, 2018 | Glen D. Stettin | Sr. VP, Clin. Res. & New Sol. | Sell | $279K (3,449 @ $81.00) |
| Jan 2, 2018 | Glen D. Stettin | Sr. VP, Clin. Res. & New Sol. | Sell | $262K (3,448 @ $76.00) |
| Dec 15, 2017 | Christine Houston | Executive VP & COO | Sell | $708K (10,104 @ $70.08) |
| Nov 1, 2017 | Phyllis S. Anderson | Sr. VP & Ch. Marketing Officer | Sell | $40K (643 @ $62.37) |
| Oct 31, 2017 | Timothy C Wentworth | President & CEO | Buy | $489K (8,000 @ $61.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.